Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent Manner

Borissoff, Julian I.; Otten, Jeroen J. T.; Heeneman, Sylvia; Leenders, Peter; van Oerle, René; Soehnlein, Oliver; Loubele, Sarah T. B. G.; Hamulyák, Karly; Hackeng, Tilman M.; Daemen, Mat J. A. P.; Degen, Jay L.; Weiler, Hartmut; Esmon, Charles T.; van Ryn, Joanne; Biessen, Erik A. L.; Spronk, Henri M. H.; ten Cate, Hugo
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Background: Variations in the blood coagulation activity, determined genetically or by medication, may alter atherosclerotic plaque progression, by influencing pleiotropic effects of coagulation proteases. Published experimental studies have yielded contradictory findings on the role of hypercoagulability in atherogenesis. We therefore sought to address this matter by extensively investigating the in vivo significance of genetic alterations and pharmacologic inhibition of thrombin formation for the onset and progression of atherosclerosis, and plaque phenotype determination. Methodology/Principal Findings: We generated transgenic atherosclerosis-prone mice with diminished coagulant or hypercoagulable phenotype and employed two distinct models of atherosclerosis. Gene-targeted 50% reduction in prothrombin (FII−/WT:ApoE−/−) was remarkably effective in limiting disease compared to control ApoE−/− mice, associated with significant qualitative benefits, including diminished leukocyte infiltration, altered collagen and vascular smooth muscle cell content. Genetically-imposed hypercoagulability in TMPro/Pro:ApoE−/− mice resulted in severe atherosclerosis, plaque vulnerability and spontaneous atherothrombosis. Hypercoagulability was associated with a pronounced neutrophilia, neutrophil hyper-reactivity, markedly increased oxidative stress, neutrophil intraplaque infiltration and apoptosis. Administration of either the synthetic specific thrombin inhibitor Dabigatran etexilate, or recombinant activated protein C (APC), counteracted the pro-inflammatory and pro-atherogenic phenotype of pro-thrombotic TMPro/Pro:ApoE−/− mice. Conclusions/Significance: We provide new evidence highlighting the importance of neutrophils in the coagulation-inflammation interplay during atherogenesis. Our findings reveal that thrombin-mediated proteolysis is an unexpectedly powerful determinant of atherosclerosis in multiple distinct settings. These studies suggest that selective anticoagulants employed to prevent thrombotic events may also be remarkably effective in clinically impeding the onset and progression of cardiovascular disease.


Related Articles

  • Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice. Fei Zheng; Shanshan Xing; Zushun Gong; Wei Mu; Qichong Xing // Mediators of Inflammation;2014, Vol. 2014, p1 

    Objectives.The role of the NLRP3 inflammasome in atherosclerosis remains controversial. The aim of this study was to determine whether inhibition ofNLRP3 signaling by lentivirus-mediatedRNAinterference could reduce atherosclerosis and stabilizes plaques. We also tried to explore the mechanisms...

  • Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice. Wan, Wuzhou; Lionakis, Michail S.; Liu, Qian; Roffê, Ester; Murphy, Philip M. // Cardiovascular Research;Mar2013, Vol. 97 Issue 3, p580 

    Aims Recent evidence suggests that both Ccr7 and its ligands, Ccl19 and Ccl21, are present in mouse and human atherosclerotic plaques; however, the role of Ccr7 in atherogenesis is still controversial. Here, we addressed this question by using the classic apolipoprotein E-deficient...

  • Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice. MacKinnon, Alison C; Liu, Xiaojun; Hadoke, Patrick WF; Miller, Mark R; Newby, David E; Sethi, Tariq // Glycobiology;Jun2013, Vol. 23 Issue 6, p654 

    Atherosclerosis is a major risk factor for cardiovascular disease (CVD) and stroke. Galectin-3 is a carbohydrate-binding lectin implicated in the pathophysiology of CVD and is highly expressed within atherosclerotic lesions in mice and humans. The object of this present study was to use genetic...

  • A1 adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice. Teng, Bunyen; Smith, Jonathan D.; Rosenfeld, Michael E.; Robinet, Peggy; Davis, Mary E.; Morrison, R. Ray; Mustafa, S. Jamal // Cardiovascular Research;Apr2014, Vol. 102 Issue 1, p157 

    Aims The goal of this study was to determine whether the A1 adenosine receptor (AR) plays a role in atherosclerosis development and to explore its potential mechanisms. Methods and results Double knockout (DKO) mice, deficient in the genes encoding A1 AR and apolipoprotein E (apoE), demonstrated...

  • IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice. Mantani, Polyxeni T.; Dunér, Pontus; Bengtsson, Eva; Alm, Ragnar; Ljungcrantz, Irena; Söderberg, Ingrid; Sundius, Lena; To, Fong; Nilsson, Jan; Björkbacka, Harry; Fredrikson, Gunilla Nordin // PLoS ONE;Jan2015, Vol. 10 Issue 1, p1 

    Objective: IL-25 has been implicated in the initiation of type 2 immunity and in the protection against autoimmune inflammatory diseases. Recent studies have identified the novel innate lymphoid type 2 cells (ILC2s) as an IL-25 target cell population. The purpose of this study was to evaluate...

  • Periaortic Brown Adipose Tissue as a Major Determinant of [18F]-Fluorodeoxyglucose Vascular Uptake in Atherosclerosis-Prone, ApoE−/− Mice. Toczek, Jakub; Broisat, Alexis; Perret, Pascale; Desruet, Marie-Dominique; Fagret, Daniel; Riou, Laurent M.; Ghezzi, Catherine // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Background: [18F]-fluorodeoxyglucose (FDG) has been suggested for the clinical and experimental imaging of inflammatory atherosclerotic lesions. Significant FDG uptake in brown adipose tissue (BAT) has been observed both in humans and mice. The objective of the present study was to investigate...

  • Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation. Wei, Hsi-Ju; Li, Yi-Heng; Shi, Guey-Yueh; Liu, Shu-Lin; Chang, Po-Chiao; Kuo, Cheng-Hsiang; Wu, Hua-Lin // Cardiovascular Research;Nov2011, Vol. 92 Issue 2, p317 

    Aims Thrombin modulates the formation of atherosclerotic lesions by stimulating a variety of cellular effects through protease-activated receptor-1 (PAR-1) activation. Thrombomodulin (TM) inhibits thrombin effects by binding thrombin through its domains 2 and 3 (TMD23). We investigated whether...

  • Effects of OX40-OX40L Interaction on the Nuclear Factor of Activated T Cells c1 in ApoE-Deficient Mice. Yan, Jin-chuan; Xu, Liang-jie; Wang, Cui-ping; Wang, Zhong-qun // Inflammation;Feb2014, Vol. 37 Issue 1, p205 

    We previously reported the emerging role of OX40-OX40L interaction in inflammation and atherosclerosis. However, the mechanism by which OX40-OX40L interaction contributes to pathogenesis is poorly understood. This study investigated the effects of OX40-OX40L interaction on the nuclear factor of...

  • Adiponectin Receptor 2 Deficiency Results in Reduced Atherosclerosis in the Brachiocephalic Artery in Apolipoprotein E Deficient Mice. Lindgren, Anna; Levin, Malin; Rodrigo Blomqvist, Sandra; Wikström, Johannes; Ahnmark, Andrea; Mogensen, Christina; Böttcher, Gerhard; Bohlooly-Y, Mohammad; Borén, Jan; Gan, Li-Ming; Lindén, Daniel // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Adiponectin has been shown to have beneficial cardiovascular effects and to signal through the adiponectin receptors, AdipoR1 and AdipoR2. The original aim of this study was to investigate the effect of combined AdipoR1 and AdipoR2 deficiency (AdipoR1-/-AdipoR2-/-) on atherosclerosis. However,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics